BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11959590)

  • 1. Antagonism between aminoglycosides and beta-lactams in a methicillin-resistant Staphylococcus aureus isolate involves induction of an aminoglycoside-modifying enzyme.
    Ida T; Okamoto R; Nonoyama M; Irinoda K; Kurazono M; Inoue M
    Antimicrob Agents Chemother; 2002 May; 46(5):1516-21. PubMed ID: 11959590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of the genes encoding aminoglycoside-modifying enzymes and methicillin resistance among clinical isolates of Staphylococcus aureus in Tehran, Iran.
    Yadegar A; Sattari M; Mozafari NA; Goudarzi GR
    Microb Drug Resist; 2009 Jun; 15(2):109-13. PubMed ID: 19496674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals.
    Schmitz FJ; Fluit AC; Gondolf M; Beyrau R; Lindenlauf E; Verhoef J; Heinz HP; Jones ME
    J Antimicrob Chemother; 1999 Feb; 43(2):253-9. PubMed ID: 11252331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain.
    Fernández-Martínez M; Miró E; Ortega A; Bou G; González-López JJ; Oliver A; Pascual A; Cercenado E; Oteo J; Martínez-Martínez L; Navarro F;
    Int J Antimicrob Agents; 2015 Aug; 46(2):157-63. PubMed ID: 26022930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of aminoglycoside-modifying enzymes by susceptibility testing: epidemiology of methicillin-resistant Staphylococcus aureus in Japan.
    Ida T; Okamoto R; Shimauchi C; Okubo T; Kuga A; Inoue M
    J Clin Microbiol; 2001 Sep; 39(9):3115-21. PubMed ID: 11526138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. IV. Aminoglycoside-modifying enzyme AAC(6')/APH(2") is responsible for arbekacin-resistance enhanced by bleomycin.
    Inouye Y; Hashimoto M; Sugiyama M; Takesue Y; Santo T; Yokoyama T
    Hiroshima J Med Sci; 1994 Sep; 43(3):87-92. PubMed ID: 7534753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to Aminoglycosides of Methicillin-Resistant Strains of Staphylococcus aureus, Originating in the Surgical and Transplantation Wards of the Warsaw Clinical Center-A Retrospective Analysis.
    Szymanek-Majchrzak K; Mlynarczyk A; Kawecki D; Pacholczyk M; Durlik M; Deborska-Materkowska D; Paczek L; Mlynarczyk G
    Transplant Proc; 2018 Sep; 50(7):2170-2175. PubMed ID: 30177131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel arbekacin- and amikacin-modifying enzyme of methicillin-resistant Staphylococcus aureus.
    Fujimura S; Tokue Y; Takahashi H; Kobayashi T; Gomi K; Abe T; Nukiwa T; Watanabe A
    FEMS Microbiol Lett; 2000 Sep; 190(2):299-303. PubMed ID: 11034295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conjugal transfer of aac(6')Ie-aph(2″)Ia gene from native species and mechanism of regulation and cross resistance in Enterococcus faecalis MCC3063 by real time-PCR.
    Jaimee G; Halami PM
    Microb Pathog; 2017 Sep; 110():546-553. PubMed ID: 28774859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in the gentamicin and arbekacin susceptibility of methicillin-resistant Staphylococcus aureus and the genes encoding aminoglycoside-modifying enzymes.
    Barada K; Hanaki H; Ikeda S; Yamaguchi Y; Akama H; Nakae T; Inamatsu T; Sunakawa K
    J Infect Chemother; 2007 Apr; 13(2):74-8. PubMed ID: 17458673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of Aminoglycoside-Modifying Enzymes and Molecular Analysis of the Coagulase Gene in Clinical Isolates of Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus.
    Seyedi-Marghaki F; Kalantar-Neyestanaki D; Saffari F; Hosseini-Nave H; Moradi M
    Microb Drug Resist; 2019; 25(1):47-53. PubMed ID: 29708846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic and genotypic evaluation of aminoglycoside resistance in clinical isolates of staphylococci in Tehran, Iran.
    Emaneini M; Taherikalani M; Eslampour MA; Sedaghat H; Aligholi M; Jabalameli F; Shahsavan S; Sotoudeh N
    Microb Drug Resist; 2009 Jun; 15(2):129-32. PubMed ID: 19432516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aminoglycosides resistance of methicillin-resistant Staphylococcus aureus].
    Okamoto R; Okubo T
    Nihon Rinsho; 1992 May; 50(5):1036-41. PubMed ID: 1324330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic and genotypic aminoglycoside resistance in blood culture isolates of coagulase-negative staphylococci from a single neonatal intensive care unit, 1989-2000.
    Klingenberg C; Sundsfjord A; Rønnestad A; Mikalsen J; Gaustad P; Flaegstad T
    J Antimicrob Chemother; 2004 Nov; 54(5):889-96. PubMed ID: 15471996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between arbekacin-susceptibility and aminoglycoside-resistant gene of methicillin-resistant Staphylococcus aureus (MRSA)].
    Tabata M; Shimizu M; Araake M; Ogawa H
    Jpn J Antibiot; 2003 Feb; 56(1):36-43. PubMed ID: 12723397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Susceptibility of methicillin-resistant Staphylococcus aureus to various antibiotics. Classification by aminoglycoside-modifying enzymes and antibiotics active against MRSA].
    Kondo S; Ikeda Y; Hattori S; Hamada M; Takeuchi T
    Jpn J Antibiot; 1991 Nov; 44(11):1211-5. PubMed ID: 1664469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-occurrence of aminoglycoside and β-lactam resistance mechanisms in aminoglycoside- non-susceptible Escherichia coli isolated in the Zurich area, Switzerland.
    Bodendoerfer E; Marchesi M; Imkamp F; Courvalin P; Böttger EC; Mancini S
    Int J Antimicrob Agents; 2020 Jul; 56(1):106019. PubMed ID: 32422315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Emergence of arbekacin resistant strains among methicillin-resistant Staphylococcus aureus].
    Suzuki T; Fujita K; Nagamachi Y; Okubo T
    Jpn J Antibiot; 1994 Jun; 47(6):634-9. PubMed ID: 8072171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro activity of arbekacin alone and in combination with vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus.
    You I; Kariyama R; Zervos MJ; Kumon H; Chow JW
    Diagn Microbiol Infect Dis; 2000 Jan; 36(1):37-41. PubMed ID: 10744365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a bifunctional aminoglycoside-modifying enzyme with novel substrate specificity and its gene from a clinical isolate of methicillin-resistant Staphylococcus aureus with high arbekacin resistance.
    Ishino K; Ishikawa J; Ikeda Y; Hotta K
    J Antibiot (Tokyo); 2004 Oct; 57(10):679-86. PubMed ID: 15638329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.